Global Deoxynucleotide Triphosphates (dNTPs) Market Research Report 2023-Competitive Analysis, Status and Outlook by Type, Downstream Industry, and Geography, Forecast to 2029

Global Deoxynucleotide Triphosphates (dNTPs) Market Research Report 2023-Competitive Analysis, Status and Outlook by Type, Downstream Industry, and Geography, Forecast to 2029

Deoxynucleotide triphosphates (dNTPs) are nucleoside triphosphates containing deoxyribose. They are the building blocks of DNA, and they will lose two phosphate groups when incorporating deoxyribonucleic acid in the replication process. Members of DNA transporters include dNTPs include deoxyadenosine triphosphate (dATP), deoxythymidine triphosphate (dTTP), deoxycytidine triphosphate (dCTP), deoxyguanosine triphosphate (dGTP) and deoxyuridine triphosphate (dUTP). Deoxynucleotide triphosphates (dNTPs) are widely used in pharmacy and research.

Market Overview:

The latest research study on the global Deoxynucleotide Triphosphates (dNTPs) market finds that the global Deoxynucleotide Triphosphates (dNTPs) market reached a value of USD 280.01 million in 2022. It’s expected that the market will achieve USD 489.9 million by 2028, exhibiting a CAGR of 9.77% during the forecast period.

Covid-19's nose swab PCR test is the most accurate and reliable test for diagnosing Covid-19. Covid-19's PCR test is a test used to diagnose people who are currently infected with novel coronavirus virus, which is the coronavirus causing Covid-19. Deoxynucleotide triphosphate (dNTP) is the basic component of nucleic acid molecule, so it is an essential component of PCR mixture, because new (amplified) DNA cannot be produced without them. Under the influence of COVID-19 epidemic, the number of patients in the world is increasing. As of June 30, 2021, the number of confirmed cases in COVID-19 has reached 182,580,354 and the death toll is 3,953,846. In order to diagnose whether Covid-19 is infected or not, PCR test has become a necessary means of detection, which is helpful for the government to control the disease. The demand for PCR test is growing rapidly, so the demand for Deoxynucleotide Triphosphates (dNTPs) is soaring. Covid-19 will promote the demand growth of Deoxynucleotide Triphosphates (dNTPs) industry.

Region Overview:

In 2022, the share of the Deoxynucleotide Triphosphates (dNTPs) market in North America stood at 36.51%.

Company Overview:

Thermo Scientific is one of the major players operating in the Deoxynucleotide Triphosphates (dNTPs) market, holding a share of 22.31% in 2023.

Thermo Scientific

Thermo Fisher Scientific is an American supplier of scientific instrumentation, reagents and consumables, and software and services to healthcare, life science, and other laboratories in academia, government, and industry (including in the biotechnology and pharmaceutical sectors). Based in Waltham, Massachusetts, Thermo Fisher was created in 2006 by the merger of Thermo Electron and Fisher Scientific.

Merck Millipore

Merck Millipore was the brand used by Merck Group's (not US-based Merck & Co.) global life science business until 2015 when the company re-branded. It was formed when Merck acquired the Millipore Corporation in 2010. Merck is a supplier to the life science industry.

Segmentation Overview:

By type, Liquid segment accounted for the largest share of market in 2022.

Application Overview:

By application, the Pharmaceutical segment occupied the biggest share from 2018 to 2022.

Key Companies in the global Deoxynucleotide Triphosphates (dNTPs) market covered in Chapter 3:

Thermo Scientific
Cytiva
Qiagen
Geneaid
Merck Millipore
Promega
NEB
Jena Bioscience
Meridian Bioscience
Takara Bio

In Chapter 4 and Chapter 14.2, on the basis of types, the Deoxynucleotide Triphosphates (dNTPs) market from 2018 to 2029 is primarily split into:

Liquid
Solid

In Chapter 5 and Chapter 14.3, on the basis of Downstream Industry, the Deoxynucleotide Triphosphates (dNTPs) market from 2018 to 2029 covers:

Pharmaceutical
Research Institutions

Geographically, the detailed analysis of consumption, revenue, market share and growth rate, historic and forecast (2018-2029) of the following regions are covered in Chapter 8 to Chapter 14:

North America (United States, Canada)
Europe (Germany, UK, France, Italy, Spain, Russia, Netherlands, Turkey, Switzerland, Sweden)
Asia Pacific (China, Japan, South Korea, Australia, India, Indonesia, Philippines, Malaysia)
Latin America (Brazil, Mexico, Argentina)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa)